Computer-Assisted Analysis of the Interactions of Macrocyclic Inhibitors with wild Type and Mutant D168A Hepatitis C Virus NS3 Serine Protease

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 1, 2006-02 ,pp. : 17-28

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 3-16

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis C NS3 protease inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 663-665

Informa Healthcare

Access to resources Recommend Favorite

Advances in the Development of Macrocyclic Inhibitors of Hepatitis C Virus NS3-4A Protease

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1403-1422

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis C Virus Serine Protease Inhibitors: Current Progress and Future Challenges

By  

Current Medicinal Chemistry, Vol. 8, Iss. 8, 2001-07 ,pp. : 919-932

Bentham Science Publishers

Access to resources Recommend Favorite